Investor Relations


$ 62.54

0.62 (1.00%)

Day High: 62.83
Day Low:  61.57
Volume:    270,200

4:00 PM ET
Oct 5, 2015

Delayed at least 20 min., by eSignal.

Stock price graph

Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Cyberonics, Inc.'s financial performance into perspective.

View all »   RSSRecent Releases

Sep 28, 2015
Extended Follow-Up Of ANTHEM-HF Patients Shows That Benefits Of Autonomic Regulation Therapy Are Maintained After 12 Months

Sep 23, 2015
High Court of England and Wales Issues Order Approving Completion of Merger of Sorin S.P.A. with and into LivaNova PLC

Shareholder Tools                         

Contact Us

100 Cyberonics Boulevard
Houston, Texas USA 77058



Investor Relations




Transfer Agent Information

P.O. BOX 30170
College Station, TX 77842-3170

Overnight correspondence should be sent to:

211 Quality Circle, Suite 210
College Station, TX 77845

Shareholder website

Shareholder online inquiries

Proud Member MDMAAdvaMed: Code of ethics supporter

© Cyberonics, Inc. 2015 | All rights reserved.